Patients May Become Immune to Botulinum Toxin Treatments

TUESDAY, Dec. 11, 2018 -- About 15 percent of patients treated with botulinum toxin type A (BoNT/A) for dystonia or spasticity can develop an immune response to the treatment itself, according to a study published online Nov. 21 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news